Detalles de la búsqueda
1.
Effect on blood lipids of two daily servings of Camembert cheese. An intervention trial in mildly hypercholesterolemic subjects.
Int J Food Sci Nutr
; 65(8): 1013-8, 2014 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-25095811
2.
Assessment of genetically modified maize MON 89034 × 1507 × MON 88017 × 59122 and 8 out of 10 of its subcombinations for renewal authorisation under Regulation (EC) No 1829/2003 (dossier GMFF-2022-9170).
EFSA J
; 22(4): e8715, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-38686342
3.
Assessment of genetically modified maize MON 89034 × 1507 × NK603 for renewal authorisation under Regulation (EC) No 1829/2003 (application GMFF-2022-3670).
EFSA J
; 22(4): e8716, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-38681739
4.
Assessment of genetically modified maize MON 810 for renewal authorisation under Regulation (EC) No 1829/2003 (dossier GMFF-2022-9450).
EFSA J
; 22(1): e8489, 2024 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-38250501
5.
Assessment of genetically modified maize DP915635 for food and feed uses, under regulation (EC) No 1829/2003 (application EFSA-GMO-NL-2020-172).
EFSA J
; 22(1): e8490, 2024 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-38235311
6.
Assessment of genetically modified maize DP202216 for food and feed uses, under Regulation (EC) No 1829/2003 (application EFSA-GMO-NL-2019-159).
EFSA J
; 22(3): e8655, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-38510324
7.
Assessment of genetically modified maize MON 94804 (application GMFF-2022-10651).
EFSA J
; 22(4): e8714, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-38681741
8.
Assessment of genetically modified maize DP23211 for food and feed uses, under Regulation (EC) No 1829/2003 (application EFSA-GMO-NL-2019-163).
EFSA J
; 22(1): e8483, 2024 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-38239495
9.
Nutritional safety and suitability of a specific protein hydrolysate derived from a whey protein concentrate and used in an infant formula and follow-on formula manufactured from hydrolysed protein by FrieslandCampina Nederland B.V.
EFSA J
; 21(7): e08063, 2023 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-37469354
10.
Choline and contribution to normal liver function of the foetus and exclusively breastfed infants: evaluation of a health claim pursuant to Article 14 of Regulation (EC) No 1924/2006.
EFSA J
; 21(7): e08115, 2023 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-37502017
11.
Animal dietary exposure in the risk assessment of feed derived from genetically modified plants.
EFSA J
; 21(1): e07732, 2023 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-36698485
12.
Risk assessment of additional information on maize MIR162.
EFSA J
; 21(4): e07935, 2023 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-37077301
13.
Appethyl® and reduction of body weight: evaluation of a health claim pursuant to Article 13(5) of Regulation (EC) No 1924/2006.
EFSA J
; 21(10): e08239, 2023 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-37829005
14.
Assessment of genetically modified oilseed rape MS8, RF3 and MS8 × RF3 for renewal authorisation under Regulation (EC) No 1829/2003 (application EFSA-GMO-RX-024).
EFSA J
; 21(4): e07934, 2023 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-37122285
15.
Assessment of genetically modified maize GA21 × T25 for food and feed uses, under Regulation (EC) No 1829/2003 (application EFSA-GMO-DE-2016-137).
EFSA J
; 21(1): e07729, 2023 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-36721864
16.
Assessment of genetically modified cotton COT102 for food and feed uses, under Regulation (EC) No 1829/2003 (application EFSA-GMO-DE-2017-141).
EFSA J
; 21(6): e08031, 2023 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-37377664
17.
Assessment of genetically modified maize Bt11 × MIR162 × MIR604 × MON 89034 × 5307 × GA21 and 30 subcombinations, for food and feed uses, under Regulation (EC) No 1829/2003 (application EFSA-GMO-DE-2018-149).
EFSA J
; 21(6): e08011, 2023 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-37284025
18.
Assessment of genetically modified maize MON 87419 for food and feed uses, under Regulation (EC) No 1829/2003 (application EFSA-GMO-NL-2017-140).
EFSA J
; 21(1): e07730, 2023 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-36698492
19.
Hepatitis C virus-specific cellular immune responses in individuals with no evidence of infection.
Virol J
; 9: 76, 2012 Mar 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-22455516
20.
Scientific advice related to nutrient profiling for the development of harmonised mandatory front-of-pack nutrition labelling and the setting of nutrient profiles for restricting nutrition and health claims on foods.
EFSA J
; 20(4): e07259, 2022 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-35464873